Arrowhead Pharmaceuticals (NasdaqGS:ARWR) 2025 Conference Transcript

Arrowhead Pharmaceuticals (NasdaqGS:ARWR) 2025 Conference November 19, 2025 06:00 AM ET Company ParticipantsChristopher Anzalone - CEOConference Call ParticipantsMaury Raycroft - AnalystMaury RaycroftHi, everyone. My name is Maury Raycroft. I'm one of the biotech analysts at Jefferies. I'd like to welcome Chris Anzalone, the CEO of Arrowhead. Thanks so much for joining us today, Chris, and congrats on the FCS approval yesterday.Christopher AnzaloneThanks very much. It's a pleasure to be here, as always, and ...